Citation Impact
Citing Papers
RhoA-Dependent Regulation of Cell Migration by the Tumor Suppressor hSNF5/INI1
2008
Interleukin-1 in the pathogenesis and treatment of inflammatory diseases
2011 Standout
Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade
2005
Genomic Analysis Using High-Density Single Nucleotide Polymorphism-Based Oligonucleotide Arrays and Multiplex Ligation-Dependent Probe Amplification Provides a Comprehensive Analysis of INI1/SMARCB1 in Malignant Rhabdoid Tumors
2009
Blood leukocyte microarrays to diagnose systemic onset juvenile idiopathic arthritis and follow the response to IL-1 blockade
2007
Effective treatment of severe COVID-19 patients with tocilizumab
2020 Standout
Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma
2010 StandoutScience
Infrared molecular fingerprinting of blood-based liquid biopsies for the detection of cancer
2021 StandoutNobel
Chromosomal CGH identifies patients with a higher risk of relapse in neuroblastoma without MYCN amplification
2007
Temporal requirements for ISL1 in sympathetic neuron proliferation, differentiation, and diversification
2018
SMARCB1/INI1 Protein Expression in Round Cell Soft Tissue Sarcomas Associated With Chromosomal Translocations Involving EWS: A Special Reference to SMARCB1/INI1 Negative Variant Extraskeletal Myxoid Chondrosarcoma
2008
The German etanercept registry for treatment of juvenile idiopathic arthritis
2004
The biologic basis for neuroblastoma heterogeneity and risk stratification
2005
Medical Treatment of Juvenile Idiopathic Arthritis
2005
Clinical experience of IL-6 blockade in rheumatic diseases—Implications on IL-6 biology and disease pathogenesis
2014
MYC on the Path to Cancer
2012 Standout
Genetic effects on gene expression across human tissues
2017 StandoutNature
CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010–2014
2017 Standout
Interleukin 6: from bench to bedside
2006
Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial
2008
Precision oncology in the age of integrative genomics
2018
Safety and efficacy of once weekly etanercept 0.8 mg/kg in a multicentre 12 week trial in active polyarticular course juvenile idiopathic arthritis
2009
Autoinflammatory Disease Reloaded: A Clinical Perspective
2010 Standout
Long‐term safety and effectiveness of etanercept in children with selected categories of juvenile idiopathic arthritis
2009
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice
2016
Juvenile idiopathic arthritis
2007 Standout
Open label phase II trial of single, ascending doses of MRA in Caucasian children with severe systemic juvenile idiopathic arthritis: proof of principle of the efficacy of IL-6 receptor blockade in this type of arthritis and demonstration of prolonged clinical improvement
2005
Ulcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters Committee
2004 Standout
SWI/SNF nucleosome remodellers and cancer
2011 Standout
IL‐6: Regulator of Treg/Th17 balance
2010 Standout
Diagnosis of distal 22q11.2 deletion syndrome in a patient with a teratoid/rhabdoid tumour
2010
22q11.21 Deletion Syndromes: A Review of Proximal, Central, and Distal Deletions and Their Associated Features
2015 Standout
Etanercept therapy for patients with psoriatic arthritis and concurrent hepatitis C virus infection: Report of 3 cases
2004
Risk of new-onset uveitis in patients with juvenile idiopathic arthritis treated with anti-TNFα agents
2006
Immunohistochemistry of INI1 Expression: A New Tool for Old Challenges in CNS and Soft Tissue Pathology
2007
Long‐term open‐label preliminary study of the safety and efficacy of leflunomide in patients with polyarticular‐course juvenile rheumatoid arthritis
2005
Current and future perspectives of liquid biopsies in genomics-driven oncology
2018 Standout
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
2016 Standout
Biologic Agents for the Treatment of Juvenile Rheumatoid Arthritis
2004
Delivery technologies for cancer immunotherapy
2019 Standout
Epigenetics in cancer
2009 Standout
The SWI/SNF complex and cancer
2009
Sensors of the innate immune system: their link to rheumatic diseases
2010 StandoutNobel
Monitoring neutrophil activation in juvenile rheumatoid arthritis by S100A12 serum concentrations
2004
IL-6 in Inflammation, Immunity, and Disease
2014 Standout
Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France
2007
Alterations in the SMARCB1 (INI1) tumor suppressor gene in familial schwannomatosis
2008
Graves' Ophthalmopathy
2010 Standout
Caspase Functions in Cell Death and Disease
2013 Standout
Clinical and immunologic correlates of response to PD-1 blockade in a patient with metastatic renal medullary carcinoma
2017
MicroRNA biogenesis pathways in cancer
2015 Standout
Etanercept (Enbrel)-Associated Inflammatory Eye Disease: Case Report and Review of the Literature
2006
Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy
2013 Standout
TNFα blockade in human diseases: An overview of efficacy and safety
2007
Recent Advances in Neuroblastoma
2010
Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma
2012
Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry
2008
High-density single nucleotide polymorphism array analysis in patients with germline deletions of 22q11.2 and malignant rhabdoid tumor
2007
Systemic JIA: new developments in the understanding of the pathophysiology and therapy
2009
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Spectrum of SMARCB1/INI1 mutations in familial and sporadic rhabdoid tumors
2010
Loss of SMARCB1/INI1 expression in poorly differentiated chordomas
2010
Use of adalimumab in patients with juvenile idiopathic arthritis refractory to etanercept and/or infliximab
2009
The Third Revolution in Sequencing Technology
2018
Adalimumab in the therapy of uveitis in childhood
2006
Systematic analysis of the antiproliferative effects of novel and standard anticancer agents in rhabdoid tumor cell lines
2010
Neuroblastoma
2007 Standout
A single nucleotide polymorphism associated with isolated cleft lip and palate, thyroid cancer and hypothyroidism alters the activity of an oral epithelium and thyroid enhancer near FOXE1
2015
Clinical Remission in Patients with Systemic Juvenile Idiopathic Arthritis Treated with Anti-Tumor Necrosis Factor Agents
2009
Epigenetic modifications and human disease
2010 Standout
Cytokines in the pathogenesis of rheumatoid arthritis
2007 Standout
New insights in systemic juvenile idiopathic arthritis--from pathophysiology to treatment
2007
Molecular profiling for precision cancer therapies
2020
Mining museums for historical DNA: advances and challenges in museomics
2021 Standout
ROS and the DNA damage response in cancer
2018 Standout
Goldenhar phenotype in a child with distal 22q11.2 deletion and intracranial atypical teratoid rhabdoid tumor
2009
Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy
2020 Standout
A case of macrophage activation syndrome successfully treated with anakinra
2008
Biologics for the treatment of juvenile idiopathic arthritis: a systematic review and critical analysis of the evidence
2007
Autologous stem cell transplantation for refractory juvenile idiopathic arthritis: analysis of clinical effects, mortality, and transplant related morbidity
2004
Glycosylation in cancer: mechanisms and clinical implications
2015 Standout
Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: the Dutch national register
2008
The kinesin KIF1Bβ acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor
2008 StandoutNobel
Childhood Brain Tumor Epidemiology: A Brain Tumor Epidemiology Consortium Review
2014
HIF-1α is required for development of the sympathetic nervous system
2019 StandoutNobel
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011–2015
2018 Standout
Hijacking the Chromatin Remodeling Machinery: Impact ofSWI/SNFPerturbations in Cancer
2009
Childhood and adolescent cancer statistics, 2014
2014 Standout
Current concepts in the diagnosis and management of cytokine release syndrome
2014 Standout
Targeting the interleukin‐6 receptor: A new treatment for systemic juvenile idiopathic arthritis?
2005
2016 US lymphoid malignancy statistics by World Health Organization subtypes
2016 Standout
Inactivation of the PBRM1 tumor suppressor gene amplifies the HIF-response in VHL −/− clear cell renal carcinoma
2017 StandoutNobel
Immunological and Inflammatory Functions of the Interleukin-1 Family
2009 Standout
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012–2016
2019 Standout
2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings
2007 Standout
TNF‐mediated inflammatory disease
2007 Standout
The roles of ARID1A in gynecologic cancer
2013
The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report
2008 Standout
Etanercept treatment in patients with refractory systemic onset juvenile rheumatoid arthritis.
2005
GALNT9 Gene Expression Is a Prognostic Marker in Neuroblastoma Patients
2012
Hematological Problems in Pediatric Intensive Care
2013 Standout
Cancer treatment and survivorship statistics, 2014
2014 Standout
Works of Franck Bourdeaut being referenced
Same-day genomic and epigenomic diagnosis of brain tumors using real-time nanopore sequencing
2017
Cholinergic switch associated with morphological differentiation in neuroblastoma
2009
Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type
2003
Germline Mutations of the Paired–Like Homeobox 2B (PHOX2B) Gene in Neuroblastoma
2004
Extra‐renal non‐cerebral rhabdoid tumours
2008
Stepwise occurrence of a complex unbalanced translocation in neuroblastoma leading to insertion of a telomere sequence and late chromosome 17q gain
2005
hSNF5/INI1‐deficient tumours and rhabdoid tumours are convergent but not fully overlapping entities
2006
Balanced Translocations Disrupting SMARCB1 Are Hallmark Recurrent Genetic Alterations in Renal Medullary Carcinomas
2015
Rubinstein-Taybi syndrome predisposing to non-WNT, non-SHH, group 3 medulloblastoma
2013
Embryonal tumor with multilayered rosettes: Diagnostic tools update and review of the literature
2013
Accumulation of Segmental Alterations Determines Progression in Neuroblastoma
2010
Malformations, genetic abnormalities, and wilms tumor
2013
SWI/SNF Chromatin Remodeling and Human Malignancies
2014